B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1799 | 2020 |
Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy J Gao, LZ Shi, H Zhao, J Chen, L Xiong, Q He, T Chen, J Roszik, ... Cell 167 (2), 397-404. e9, 2016 | 1238 | 2016 |
CrossMap: a versatile tool for coordinate conversion between genome assemblies H Zhao, Z Sun, J Wang, H Huang, JP Kocher, L Wang Bioinformatics 30 (7), 1006-1007, 2014 | 630 | 2014 |
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer J Gao, JF Ward, CA Pettaway, LZ Shi, SK Subudhi, LM Vence, H Zhao, ... Nature medicine 23 (5), 551-555, 2017 | 585 | 2017 |
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer J Blando, A Sharma, MG Higa, H Zhao, L Vence, SS Yadav, J Kim, ... Proceedings of the National Academy of Sciences 116 (5), 1692-1697, 2019 | 303 | 2019 |
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma S Goswami, T Walle, AE Cornish, S Basu, S Anandhan, I Fernandez, ... Nature medicine 26 (1), 39-46, 2020 | 284 | 2020 |
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen, GJ Bubley, SP Balk, W Li Molecular Cancer Research 13 (1), 98-106, 2015 | 201 | 2015 |
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy S Goswami, I Apostolou, J Zhang, J Skepner, S Anandhan, X Zhang, ... The Journal of clinical investigation 128 (9), 3813-3818, 2018 | 191 | 2018 |
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, AM Bailey, L Strong, ... Annals of Oncology 27 (5), 795-800, 2016 | 190 | 2016 |
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities SA Tahir, J Gao, Y Miura, J Blando, RSS Tidwell, H Zhao, SK Subudhi, ... Proceedings of the National Academy of Sciences 116 (44), 22246-22251, 2019 | 174 | 2019 |
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer SK Subudhi, L Vence, H Zhao, J Blando, SS Yadav, Q Xiong, A Reuben, ... Science translational medicine 12 (537), eaaz3577, 2020 | 132 | 2020 |
Clinical actionability enhanced through deep targeted sequencing of solid tumors K Chen, F Meric-Bernstam, H Zhao, Q Zhang, N Ezzeddine, L Tang, Y Qi, ... Clinical chemistry 61 (3), 544-553, 2015 | 107 | 2015 |
Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes AM Hillmer, F Yao, K Inaki, WH Lee, PN Ariyaratne, ASM Teo, XY Woo, ... Genome research 21 (5), 665-675, 2011 | 106 | 2011 |
Recovering genome rearrangements in the mammalian phylogeny H Zhao, G Bourque Genome research 19 (5), 934-942, 2009 | 100 | 2009 |
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma TH Ho, IY Park, H Zhao, P Tong, MD Champion, H Yan, FA Monzon, ... Oncogene 35 (12), 1565-1574, 2016 | 89 | 2016 |
On the complexity of finding emerging patterns L Wang, H Zhao, G Dong, J Li Theoretical Computer Science 335 (1), 15-27, 2005 | 75 | 2005 |
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors B Hassan, A Akcakanat, T Sangai, KW Evans, F Adkins, AK Eterovic, ... Oncotarget 5 (18), 8544, 2014 | 71 | 2014 |
Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes PF McAuliffe, KW Evans, A Akcakanat, K Chen, X Zheng, H Zhao, ... PloS one 10 (9), e0136851, 2015 | 62 | 2015 |
Characterization and comparison of GITR expression in solid tumors L Vence, SL Bucktrout, I Fernandez Curbelo, J Blando, BM Smith, ... Clinical Cancer Research 25 (21), 6501-6510, 2019 | 47 | 2019 |
Bias from removing read duplication in ultra-deep sequencing experiments KC Wanding Zhou, Tenghui Chen, Hao Zhao, Agda Karina Bioinformatics, 2014 | 47 | 2014 |